SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-specific antibodies in different populations has remained unclear. Here, we report very low SARS-CoV-2 seroprevalence in two San Francisco Bay Area populations. Seroreactivity was 0.26% in 387 hospitalize...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Dianna L., Goldgof, Gregory M., Shy, Brian R., Levine, Andrew G., Balcerek, Joanna, Bapat, Sagar P., Prostko, John, Rodgers, Mary, Coller, Kelly, Pearce, Sandra, Franz, Sergej, Du, Li, Stone, Mars, Pillai, Satish K., Sotomayor-Gonzalez, Alicia, Servellita, Venice, Martin, Claudia Sanchez San, Granados, Andrea, Glasner, Dustin R., Han, Lucy M., Truong, Kent, Akagi, Naomi, Nguyen, David N., Neumann, Neil M., Qazi, Daniel, Hsu, Elaine, Gu, Wei, Santos, Yale A., Custer, Brian, Green, Valerie, Williamson, Phillip, Hills, Nancy K., Lu, Chuanyi M., Whitman, Jeffrey D., Stramer, Susan L., Wang, Candace, Reyes, Kevin, Hakim, Jill M. C., Sujishi, Kirk, Alazzeh, Fariba, Pham, Lori, Thornborrow, Edward, Oon, Ching-Ying, Miller, Steve, Kurtz, Theodore, Simmons, Graham, Hackett, John, Busch, Michael P., Chiu, Charles Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499171/
https://www.ncbi.nlm.nih.gov/pubmed/32943630
http://dx.doi.org/10.1038/s41467-020-18468-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499171/
https://www.ncbi.nlm.nih.gov/pubmed/32943630
http://dx.doi.org/10.1038/s41467-020-18468-8

Ejemplares similares